Many patients taking long acting insulin are still not at goal. Adding linagliptin may be an effective way to get to goal and reduce blood sugars….
Read More »Empagliflozin Shows Promising Results
New clinical trials reveal the new SGLT2 inhibitor lowers HbA1c as well as sitagliptin….
Read More »DPP-4 Inhibitors Don’t Increase Risk for Cardiac Events, Fatal and Non-Fatal
DPP-4 inhibitor drugs appeared to have a null effect on risk for fatal and non-fatal cardiac events in two trials….
Read More »Effectiveness of Linagliptin in Elderly Type 2’s
Linagliptin is shown to be effective and safe in lowering blood glucose levels in the elderly population….
Read More »Cyrus Desouza, MBBS, Q1: Cardiovascular Benefits of SGLT2s, GLP-1s, and DPP-4s?
Dr. Cyrus Desouza, MBBS, talks about the cardiovascular side effects of newer classes of drugs. SGLT2 inhibitors are still relatively new so there is not much information but they do show some weight loss effects, seem to lower blood pressure, and may have some CV benefits. However, we don’t know what they …
Read More »Efficacy of DPP-4 Inhibitors and Metformin as Initial Combo Therapy in Type 2 Diabetes
DPP-4 may be a credible alternative for patients unable to tolerate metformin….
Read More »Sitagliptin in Type 2 Diabetes: Great Safety and Tolerability
A new pooled analysis shows DPP-4 inhibitors have a greater safety and tolerability profile when compared to other antihyperglycemic agents….
Read More »Medical Professionals Speak Up about SGLT2 Inhibitors
When a new medication comes into the marketplace, some clinicians will begin prescribing it right away while others will wait for more information.
Read More »New DPP-4 Drug Combos for Type 2 Diabetes
Three New DPP-4 formuations approved by the FDA….
Read More »EASD: Merck’s Investigational Once-Weekly DPP-4 Inhibitor Significantly Lowered Blood Sugar in Patients with Type 2 Diabetes
Merck announced Phase IIb data for MK-3102, the company’s investigational once-weekly DPP-4 inhibitor in development for the treatment of type 2 diabetes….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.